Hitiq (ASX:HIQ) said it expects up to AU$6.3 million in potential revenue from its agreement with US-based Shock Doctor, according to a June 13 filing with the Australian bourse.
On June 11, the company signed an agreement to design a mouthguard that integrates the company's Proteqt technology, with plans to produce 20,000 units this year and 100,000 units in 2026.
The non-conditional agreement is for five years with the option to be renewed for an additional five years. The product will be distributed in Australia and the UK, the filing said.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。